Open Nav


  • Thomas Kelleher, Xylome Corporation

Seeking followup meetings

  • Date:Thursday, October 18
  • Time:11:30 AM - 11:45 AM
  • Room:Elizabethan C
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Xylome is a non-conventional yeast biotechnology company that is harnessing the power of genetics to convert low-value by-products from ethanol plants into higher value lipids, chemicals, enzymes and animal feeds.
  • Company
  • Company HQ City:Madison
  • Company HQ Country:United States
  • Company HQ State:Wisconsin                    
  • CEO/Top Company Official:Tom Kelleher, Ph.D. formerly from Amgen
  • Year Founded:2007, Active in 2013
  • Main Therapeutic Focus:Industrial & Environmental
  • Lead Product in Development :Salmon Feed and a Palm-oil Substitute
  • Development Phase of Primary Product:Discovery
  • Number Of Unlicensed Products (For Which You Are Seeking Partners) :two
  • Additional Information/Comments:Xylome has patent pending technologies for the production of a palm-oil substitute and a salmon feed for inland salmon farms that could be co-located at ethanol plants or salmon feed for export.
  • Previous and Current Investors:Wisconsin Alumni Research Foundation, Drs. Tom Kelleher and om TJeffries
  • Size of Last Investment Round:$91,000 at $4/share
  • Total Amount Raised to Date, In All Rounds:~$1,300,000
Thomas Kelleher
Xylome Corporation